Applying pharmacogenomics in therapeutics by Xiaodong Feng, Hong-Guang Xie

By Xiaodong Feng, Hong-Guang Xie

Recent advances in high-throughput gene sequencing and different omics biotechnologies have served as a springboard for the sphere of pharmacogenomics. Pharmacogenomics is now more often than not permitted because the significant determinant of variable drug defense, efficacy, and cost-effectiveness. for this reason, frequent use of pharmacogenomics for sufferer care has develop into a serious requirement. there's an remarkable urgency for aspiring and practising clinicians to develop into knowledgeable on easy methods to interpret information from pharmacogenomic checking out in education for the way forward for healthcare―i.e., custom-made medicine.

Applying Pharmacogenomics in Therapeutics offers well timed assurance of the rules, perform, and power of pharmacogenomics and custom-made medication. created from chapters contributed by way of well-established pharmacologists and scientists from US and chinese language academia and undefined, this authoritative text:

  • Demonstrates how one can practice the foundations of pharmacogenomics and its biotechnologies in sufferer care
  • Depicts using genetic biomarkers in drug discovery and improvement, laboratory medication, and medical services
  • Describes the perform of pharmacogenomics within the therapy of cancers, cardiovascular ailments, neurologic and psychiatric problems, and pulmonary diseases
  • Discusses the merging of pharmacogenomics and replacement drugs, in addition to the mixing of pharmacogenomics into pharmacoeconomics

Each bankruptcy starts off with the foremost techniques, by means of in-depth explorations of case studies or severe reviews of genetic variants/biomarkers, and concludes with questions for self-examination.

Show description

Read or Download Applying pharmacogenomics in therapeutics PDF

Best genetics books

Human Genetics

Today, human genetics is for everybody. it truly is approximately version greater than approximately health problems, and more and more in regards to the universal instead of in regards to the infrequent. as soon as an imprecise technology or an occasional cause of a strange selection of signs, human genetics is now a part of daily dialog. via coming to understand genetic backgrounds, humans can regulate their environments in additional fit methods. Genetic wisdom is, as a result, either informative and empowering. The tenth variation of Human Genetics: techniques and functions indicates scholars how and why that is correct.
clients who buy attach Plus obtain entry to the total on-line booklet model of the textbook.

Preimplantation Genetic Diagnosis

Preimplantation genetic analysis (PGD) is a key procedure in glossy reproductive medication. initially built to aid who have been vulnerable to transmitting single-gene genetic abnormalities to their kids, the improvement of the FISH approach broadened chromosome research to incorporate detection of extra advanced inherited abnormalities.

Extra info for Applying pharmacogenomics in therapeutics

Sample text

Acad Psychiatry, 2010; 34(2): 109–14. American Academy of Family Physicians. Core Educational Guidelines. Medical Genetics: Recommended Core Educational Guidelines for Family Practice Residents. AAFP, 1999. 171. Association of American Medical Colleges. Contemporary Issues in Medicine: Genetic Education. AAMC, 2004, Washington DC. 2 Principles of Pharmacogenetic Biotechnology and Testing in Clinical Practice Rui Liu, Gary Yuan Gao, and Long Ma CONTENTS Key Concepts............................................................................................................

Et al. A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet, 2009; 5(3): e1000433. A. A. Pieper. Cytochrome P450 2C9 polymorphisms: A comprehensive review of the in-vitro and human data. Pharmacogenetics, 2002; 12(3): 251–63. I. Clinical relevance of genetic polymorphisms in the human CYP2C9 gene. Eur J Clin Invest, 2003; 33(Suppl 2): 23–30. , et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

N Engl J Med, 2005; 353(16): 1659–72. 48. R. Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer. Cancer, 2005; 116(12): 2856–67. , et al. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2positive locally advanced breast cancer (the NOAH trial): A randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet, 2010; 375(9712): 377–84. , et al. Neoadjuvant treatment with trastuzumab in HER2-positive breast ­cancer: Results from the GeparQuattro study.

Download PDF sample

Rated 4.53 of 5 – based on 7 votes